Lecture 13 (Part1/4) of 1st International Deuterium Symposium
K. Krempels: A retrospective study to evaluate the effect of deuterium depletion on the survival of metastatic breast cancer patients About the lecture: K. Krempels, I. Somlyai, M. Huszár, G. Somlyai HYD LLC. for Cancer Research and Drug Development, Budapest, Hungary Breast cancer is one among the most prevalent forms of malignant tumors worldwide. Development of locally advanced, recurrent and/or metastasizing disease is the primary determinant of the outcome and represents a high risk for breast cancer patients. The anticancer effect of deuterium depleted water (DDW) has been revealed in the treatment of spontaneous malignancies in dogs and cats. The therapeutic efficacy of per os (PO) DDW treatment was also confirmed in a human, phase II double blind clinical trial on prostate cancer. The aim of the present study was to investigate the impact of DDW consumption in addition to conventional forms of treatments on the survival of metastatic breast cancer (MBC) patients. The records of 74 women suffering from MBC were retrospectively evaluated for the period between January 1993 and May 2005 and all but 6 of the 74 patients had previously undergone intensive and repeated prior conventional therapy and had limited expectations on survival time. In the 74 patients 135 distant metastases were diagnosed before DDW treatment commenced. Conventional cancer therapy was supplemented with PO DDW treatment; ie daily water intake of the patients was replaced by DDW. DDW consumption …
Categories: Metastatic Breast Cancer Tags: Deuterium, international, Lecture, Part1/4, Symposium
BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
RICHMOND, British Columbia — BioCurex Inc. today announced that the International Society of Oncology and Biomarkers Congress Scientific Committee has accepted BioCurex’s presentation on the RECAF blood test potential to monitor cancer recurrence and treatment.
Read more on GlobeNewswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Accepted, BioCurex, cancer, Data, international, Markers, Meeting, Monitoring, Presentation, Scientific
IRIS International to Acquire CLIA Certified Laboratory
IRIS International to Acquire CLIA Certified Laboratory
CHATSWORTH, Calif. — IRIS International, Inc. , a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has signed a definitive agreement to acquire AlliedPath, Inc., a private, early stage high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics for $4.7 …
Read more on GlobeNewswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Acquire, Certified, CLIA, international, IRIS, Laboratory
Survivors make a splash in international competition
Survivors make a splash in international competition
Members of Hamilton’s Knot A Breast dragon boat racing team are tickled pink.
Read more on Dundas Star News
Categories: Breast Cancer Recovery Tags: Competition, international, splash, Survivors
Novel Approaches To Cancer Therapy Investigated At International Conference In Winston-Salem
Novel Approaches To Cancer Therapy Investigated At International Conference In Winston-Salem
An international conference attended by more than 70 of the world’s leading experts and investigators in the field of Ephs and ephrins was held locally this week and hosted by Waldemar Debinski, M.D., Ph.D., director of the Brain Tumor Center of Excellence at Wake Forest University Baptist Medical Center. The bi-annual conference focused on the biggest known family of protein tyrosine kinase …
Read more on Medical News Today
Categories: Breast Cancer Organizations Tags: approaches, cancer, conference, international, Investigated, novel, Therapy, WinstonSalem